Rachel Strick

VP, Business Development & Acquisitions at AbbVie

Speaker

Vice President of Business Development & Acquisitions: Immunology, Eye Care, Specialty and Platform Technologies, AbbVie

Rachel currently oversees Business Development & Acquisitions (BD&A) for AbbVie’s Immunology, Eye Care, Specialty/Metabolics and Platform Technologies/AI teams. Her teams drive the development of external growth strategies and deal negotiations and execution. She has represented AbbVie across a wide spectrum of therapeutic areas for both inbound and outbound deal structures, including licenses, options, acquisitions/divestitures, research alliances, and other collaborations. She has completed deals with public companies, privately held start-ups, and academic institutions.

Rachel joined Abbott/AbbVie in 2009 as part of the Commercial Management Development Program. Before joining the business development team, she held various roles in Sales and Marketing and led the program management office for AbbVie’s separation from Abbott and post-merger integrations. Prior to joining Abbott, she was a strategic management consultant for firms including BCG.

In addition to her deal work, Rachel serves on the Board of Directors for the Stanley Manne Research Institute at Lurie Children’s Hospital and on the Advisory Board of Biagon, Inc. Rachel attended Stanford University, where she earned both an MBA from the Graduate School of Business and an MA from the Center for East Asian Studies. Her undergraduate degree is from Brown University, in Engineering and East Asian Studies.